The sales of nuclear imaging equipment are estimated to evolve at a CAGR of 5.4% between 2024 and 2034. The nuclear imaging equipment market size is expected to expand from USD 3 billion in 2024 to USD 5.1 billion through 2034.
Due to applied research and technological improvements, the nuclear imaging device market has been expanding steadily. The aging population's heart and neurological conditions, as well as the rising rate of cancer, are contributing factors to the nuclear imaging equipment market’s upward trend.
The nuclear imaging equipment industry is growing faster due to better healthcare facilities, more diagnostic imaging centers, better health insurance, and more advantageous reimbursement practices in emerging economies.
Attributes | Details |
---|---|
Market Value for 2024 | USD 3 billion |
Market Value for 2034 | USD 5.1 billion |
Market CAGR from 2024 to 2034 | 5.4% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Attributes | Details |
---|---|
Market Value for 2019 | USD 2.1 billion |
Market Value for 2023 | USD 2.8 billion |
Market CAGR from 2019 to 2023 | 7.1% |
In the segmented nuclear imaging equipment market analysis, SPECT systems emerge as the prevalent product category endowed by expansive research. Within applications, oncology leads the way, supported by comprehensive studies.
These discoveries underscore the significance of SPECT systems in diagnosing various conditions, particularly in oncology, reflecting a trend toward precision medicine and targeted therapies.
Attributes | Details |
---|---|
Top Product | SPECT Systems |
CAGR % 2019 to 2023 | 6.9% |
CAGR % 2024 to End of Forecast (2034) | 5.1% |
Attributes | Details |
---|---|
Top Application | Oncology |
CAGR % 2019 to 2023 | 6.6% |
CAGR % 2024 to End of Forecast (2034) | 4.8% |
Tables highlighting South Korea, Japan, China, the United States, and the United Kingdom illustrate the market's considerable potential for nuclear imaging equipment. Based on a comprehensive analysis, South Korea is considered especially promising, offering significant growth potential in the global nuclear imaging equipment market.
Country | South Korea |
---|---|
HCAGR (2019 to 2023) | 11.4% |
CAGR (2024 to 2034) | 7.2% |
Country | Japan |
---|---|
HCAGR (2019 to 2023) | 9.4% |
CAGR (2024 to 2034) | 6.5% |
Country | China |
---|---|
HCAGR (2019 to 2023) | 8.8% |
CAGR (2024 to 2034) | 6.3% |
Country | United States |
---|---|
HCAGR (2019 to 2023) | 7.8% |
CAGR (2024 to 2034) | 5.7% |
Country | United Kingdom |
---|---|
HCAGR (2019 to 2023) | 5.3% |
CAGR (2024 to 2034) | 4.3% |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
A few nuclear imaging equipment manufacturers control a large portion of the market, which fosters innovation and shapes the sector. Leading the way are reputable companies with a track record of innovation, such as Siemens Healthineers, GE Healthcare, and Koninklijke Philips N.V. The nuclear imaging equipment vendors push the envelope and establish standards for nuclear imaging technology improvements.
Other prominent nuclear imaging equipment providers, like Toshiba Corporation and Hitachi Ltd., enhance the competitive landscape with various products and services by bringing their knowledge and contributions. These producers use their advantages in manufacturing, research and development, and research to stay ahead of the nuclear imaging equipment market.
Emerging nuclear imaging equipment producers, such as Canon Medical Systems Corporation and Neusoft Medical Systems Co., Ltd., challenge conventional wisdom and spur competitiveness by bringing new ideas and inventiveness. The nuclear imaging tool market is partly dynamic because of its adaptability and commitment to meeting changing client needs.
The market's competitive dynamics are shaped by regional nuclear imaging equipment suppliers and niche specialists that provide specialized services to target market segments and geographic areas. The demand is defined by fierce competition among major nuclear imaging equipment manufacturers fueled by innovation, dependability, and a never-ending quest for excellence, guaranteeing ongoing breakthroughs and better patient outcomes.
Notable Developments
Company | Details |
---|---|
Koninklijke Philips N.V. | Mercurius Health, Elekta, and Koninklijke Philips N.V. announced in May 2023 a three-year contract under which Mercurius Health is going to set up informatics solutions and diagnostic and therapeutic oncology equipment from Elekta at the recently acquired Robert Janker Klinik cancer center in Bonn, Germany. |
Bartec Technologies Ltd. | The United Kingdom-based business Bartec Technologies Ltd., which specializes in providing, installing, and maintaining accessories and equipment for nuclear medicine and molecular imaging, was acquired by Mediso Ltd. in April 2022. It is anticipated that this acquisition will enhance Mediso's standing in the marketplaces in the UK and Ireland. |
Siemens Healthineers | Siemens Healthineers unveiled the Symbia Pro. specta, a SPECT/CT system that the FDA and CE have approved marked, in June 2022. Advanced SPECT and CT imaging technologies are included in this system. Among the noteworthy characteristics is a low-dose CT that can record up to 64 slices and provide detailed imaging. |
Canon, Inc. | Canon, Inc. decided to create a brand-new company in November 2022, naming it Canon Healthcare the United States of America INC. By strengthening its position in the United States medical market, Canon contributed to the growth of the medical industry. |
The nuclear imaging device market to secure a valuation of USD 3 billion in 2024.
The nuclear imaging instrument market is estimated to reach USD 5.1 billion by 2034.
Through 2034, the nuclear imaging system market is anticipated to expand at a 5.4% CAGR.
From 2019 to 2023, the nuclear imaging tool market recorded a 7.1% HCAGR.
The SPECT systems sector is set to accelerate at a CAGR of 5.1% from 2024 to 2034.
The oncology sector is predicted to thrive at a CAGR of 4.8% through 2034.
1. Executive Summary 2. Market Overview 3. Market Background 4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034 5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product 5.1. SPECT Systems 5.2. Hybrid PET Systems 5.3. Planar Scintigraphy 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Application 6.1. Oncology 6.2. Cardiology 6.3. Neurology 6.4. Others 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End-User 7.1. Hospitals 7.2. Imaging Centers 7.3. Academic and Research Centers 7.4. Others 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region 8.1. North America 8.2. Latin America 8.3. Western Europe 8.4. Eastern Europe 8.5. South Asia and Pacific 8.6. East Asia 8.7. Middle East and Africa 9. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 10. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 11. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 12. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 13. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 14. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 15. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 16. Key Countries Market Analysis 17. Market Structure Analysis 18. Competition Analysis 18.1. Siemens AG 18.2. GE Healthcare 18.3. Philips Healthcare 18.4. Digirad Corporation 18.5. Surgiceye GmbH 18.6. Koninklijke Philips N.V. 18.7. Toshiba Medical Systems Corporation 18.8. Neusoft Medical Systems Co., Ltd. 18.9. Mediso Medical Imaging Systems Co., Ltd 18.10. CMR Naviscan Corporation 19. Assumptions & Acronyms Used 20. Research Methodology
Explore Healthcare Insights
View Reports